REDOR NMR for drug discovery
- PMID: 24035486
- PMCID: PMC4038398
- DOI: 10.1016/j.bmcl.2013.08.064
REDOR NMR for drug discovery
Abstract
Rotational-echo double-resonance (REDOR) NMR is a powerful and versatile solid-state NMR measurement that has been recruited to elucidate drug modes of action and to drive the design of new therapeutics. REDOR has been implemented to examine composition, structure, and dynamics in diverse macromolecular and whole-cell systems, including taxol-bound microtubules, enzyme-cofactor-inhibitor ternary complexes, and antibiotic-whole-cell complexes. The REDOR approach involves the integrated design of specific isotopic labeling strategies and the selection of appropriate REDOR experiments. By way of example, this digest illustrates the versatility of the REDOR approach, with an emphasis on the practical considerations of experimental design and data interpretation.
Keywords: Drug discovery; REDOR; Solid-state NMR; Taxol; Vancomycin; Whole-cell NMR.
Copyright © 2013 Elsevier Ltd. All rights reserved.
Figures







References
-
- Gullion T, Schaefer J. Journal of Magnetic Resonance. 1989;81:196. - PubMed
-
- Toke O, Cegelski L. eMagRes. John Wiley & Sons, Ltd; 2007.
-
- Matsuoka S, Inoue M. Chemical Communications. 2009:5664. - PubMed
-
- Gullion T, Graham AW. Annual Reports on NMR Spectroscopy. Vol. Volume 65. Academic Press; 2009. p. 111.
-
- McDowell LM, Poliks B, Studelska DR, O'Connor RD, Beusen DD, Schaefer J. Journal of Biomolecular NMR. 2004;28:11. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources